Approaches of 3D printing in current drug delivery
Three-dimensional printing (3DP) is predicted to be one of the most progressive innovations within the pharmacy. Nowadays, the use of 3D printing technologies in drug delivery systems has exponentially expanded, due to its potential advantages over customizing drugs in individually adjusted doses. 3...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/edb1d955c6b447fa9c24e0da42cd3648 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:edb1d955c6b447fa9c24e0da42cd3648 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:edb1d955c6b447fa9c24e0da42cd36482021-11-22T04:31:07ZApproaches of 3D printing in current drug delivery2666-351110.1016/j.sintl.2021.100146https://doaj.org/article/edb1d955c6b447fa9c24e0da42cd36482022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S266635112100067Xhttps://doaj.org/toc/2666-3511Three-dimensional printing (3DP) is predicted to be one of the most progressive innovations within the pharmacy. Nowadays, the use of 3D printing technologies in drug delivery systems has exponentially expanded, due to its potential advantages over customizing drugs in individually adjusted doses. 3DP empowers the precise deposition of medicaments and excipients, which might cause a change in perspective in drug configuration, production, and use. It can span the medication improvement measure, from the preclinical turn of events and clinical preliminaries to frontline medical care. Though 3DP technology represents the clinical and financial advantages, some specialized and administrative challenges limit its utilization of pharmaceutical products. Accordingly, there's a prerequisite for constant development and refinement in 3DP methods to beat current limits and work with patients' particular medical services with the utilization of customized drugs in the future. This article presents a few 3DP technologies appropriate for drug fabrications with their applications in the improvement of the drug dose structures, demonstrating the feasibility of this innovation in regular commercial production with regulatory assessment.Snehamayee MohapatraRajat Kumar KarPrasanta Kumar BiswalSabitri BindhaniKeAi Communications Co., Ltd.articleThree-dimensional printing (3DP)Computer-aided designFused deposition modellingStereolithographyContinuous inkjet printingElectrical engineering. Electronics. Nuclear engineeringTK1-9971ENSensors International, Vol 3, Iss , Pp 100146- (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Three-dimensional printing (3DP) Computer-aided design Fused deposition modelling Stereolithography Continuous inkjet printing Electrical engineering. Electronics. Nuclear engineering TK1-9971 |
spellingShingle |
Three-dimensional printing (3DP) Computer-aided design Fused deposition modelling Stereolithography Continuous inkjet printing Electrical engineering. Electronics. Nuclear engineering TK1-9971 Snehamayee Mohapatra Rajat Kumar Kar Prasanta Kumar Biswal Sabitri Bindhani Approaches of 3D printing in current drug delivery |
description |
Three-dimensional printing (3DP) is predicted to be one of the most progressive innovations within the pharmacy. Nowadays, the use of 3D printing technologies in drug delivery systems has exponentially expanded, due to its potential advantages over customizing drugs in individually adjusted doses. 3DP empowers the precise deposition of medicaments and excipients, which might cause a change in perspective in drug configuration, production, and use. It can span the medication improvement measure, from the preclinical turn of events and clinical preliminaries to frontline medical care. Though 3DP technology represents the clinical and financial advantages, some specialized and administrative challenges limit its utilization of pharmaceutical products. Accordingly, there's a prerequisite for constant development and refinement in 3DP methods to beat current limits and work with patients' particular medical services with the utilization of customized drugs in the future. This article presents a few 3DP technologies appropriate for drug fabrications with their applications in the improvement of the drug dose structures, demonstrating the feasibility of this innovation in regular commercial production with regulatory assessment. |
format |
article |
author |
Snehamayee Mohapatra Rajat Kumar Kar Prasanta Kumar Biswal Sabitri Bindhani |
author_facet |
Snehamayee Mohapatra Rajat Kumar Kar Prasanta Kumar Biswal Sabitri Bindhani |
author_sort |
Snehamayee Mohapatra |
title |
Approaches of 3D printing in current drug delivery |
title_short |
Approaches of 3D printing in current drug delivery |
title_full |
Approaches of 3D printing in current drug delivery |
title_fullStr |
Approaches of 3D printing in current drug delivery |
title_full_unstemmed |
Approaches of 3D printing in current drug delivery |
title_sort |
approaches of 3d printing in current drug delivery |
publisher |
KeAi Communications Co., Ltd. |
publishDate |
2022 |
url |
https://doaj.org/article/edb1d955c6b447fa9c24e0da42cd3648 |
work_keys_str_mv |
AT snehamayeemohapatra approachesof3dprintingincurrentdrugdelivery AT rajatkumarkar approachesof3dprintingincurrentdrugdelivery AT prasantakumarbiswal approachesof3dprintingincurrentdrugdelivery AT sabitribindhani approachesof3dprintingincurrentdrugdelivery |
_version_ |
1718418196958019584 |